China allows the cultivation of Therapeutic Cannabis

Our sources in China have revealed that the Chinese government has just allowed three daughter companies of the pharmaceutical group Zhejiang Kangenbei from the Yunnan province to cultivate Cannabis for therapeutic use. They will be producing CBD from low THC plant varieties. This is an exclusive story from our partner in Europe, France Le Cannabiste.

Read more

25% increase in tariffs

Tariffs: Trump’s Trade War Will Stifle the Cannabis Industry

These proposed tariffs increases will do great harm to American businesses, medical marijuana patients, and adult use consumers while doing nothing to empower American companies to manufacture these products themselves.

Read more